Center for Addiction Medicine

Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence (Supplement)

This investigator-initiated study provides study medication and additional funding to supplement NIDA R01 DA030992 to evaluate the efficacy of a novel alpha-7 nicotinic cholinergic receptor partial agonist for reducing cognitive deficits associated with nicotine withdrawal and assess its efficacy as a smoking cessation treatment.